格隆汇1月12日丨生物制药商Immuron(IMRN.US)盘前涨12.21%报2.94美元。公司已获得美国国防部为该公司旗下Travelan药品提供的资助,这一举措是为了研究口服免疫疗法的给药方案,以供美国军队使用。Immuron是一家处于临床阶段的医疗公司,专注于一种新型特异性... 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001013762-23-002966 Act: 34 Size: 55 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001013762-23-001354 Act: 34 Size: 14 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-080126 Act: 34 Size: 3 MB 网页链接
$免疫子制药(IMRN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-23-080084 Act: 34 Size: 12 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-076212 Act: 34 Size: 74 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-075553 Act: 34 Size: 5 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-071874 Act: 34 Size: 753 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-066416 Act: 34 Size: 84 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-064719 Act: 34 Size: 51 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-059362 Act: 34 Size: 60 KB 网页链接